91 related articles for article (PubMed ID: 27768589)
1. Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population.
He BS; Xu T; Pan YQ; Wang HJ; Cho WC; Lin K; Sun HL; Gao TY; Wang SK
Oncotarget; 2016 Dec; 7(51):84872-84882. PubMed ID: 27768589
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the ERCC1 and XPF genes and risk of breast cancer in a Chinese population.
Yang Z; Fang X; Pei X; Li H
Genet Test Mol Biomarkers; 2013 Sep; 17(9):700-6. PubMed ID: 23909490
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis.
Zhang H; Ge J; Hong H; Bi L; Sun Z
World J Surg Oncol; 2017 Apr; 15(1):75. PubMed ID: 28388903
[TBL] [Abstract][Full Text] [Related]
4. A Significant Increasing Risk Association between Cigarette Smoking and
Almushawwah S; Almutairi MH; Alamri AM; Semlali A
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510255
[TBL] [Abstract][Full Text] [Related]
5. Relationship between ERCC1 and XPC polymorphisms and the susceptibility to head and neck carcinoma: A systematic review, meta-analysis, and trial sequential analysis.
Imani MM; Akbari S; Shalchi M; Sadeghi E; Sadeghi M
Arch Oral Biol; 2024 Jun; 162():105955. PubMed ID: 38479279
[TBL] [Abstract][Full Text] [Related]
6. Association Between Polymorphisms in DNA Damage Repair Pathway Genes and Female Breast Cancer Risk.
Wang Y; Sun Y; Tan M; Lin X; Tai P; Huang X; Jin Q; Yuan D; Xu T; He B
DNA Cell Biol; 2024 Apr; ():. PubMed ID: 38634815
[TBL] [Abstract][Full Text] [Related]
7. The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling.
Hoffman AE; Zheng T; Yi CH; Stevens RG; Ba Y; Zhang Y; Leaderer D; Holford T; Hansen J; Zhu Y
Cancer Prev Res (Phila); 2010 Apr; 3(4):539-48. PubMed ID: 20233903
[TBL] [Abstract][Full Text] [Related]
8. High excision repair cross-complementation group 1 expression is associated with favorable prognostic factors in breast cancer.
Kim DH; Lee H; Kim DH; Chae SW; Sohn JH; Kim K; Do SI
Oncol Lett; 2017 Oct; 14(4):4995-5003. PubMed ID: 28943968
[TBL] [Abstract][Full Text] [Related]
9. Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls.
Momozawa Y; Iwasaki Y; Parsons MT; Kamatani Y; Takahashi A; Tamura C; Katagiri T; Yoshida T; Nakamura S; Sugano K; Miki Y; Hirata M; Matsuda K; Spurdle AB; Kubo M
Nat Commun; 2018 Oct; 9(1):4083. PubMed ID: 30287823
[TBL] [Abstract][Full Text] [Related]
10. Do genetic polymorphisms of the vitamin D receptor contribute to breast/ovarian cancer? A systematic review and network meta-analysis.
Li J; Li B; Jiang Q; Zhang Y; Liu A; Wang H; Zhang J; Qin Q; Hong Z; Li BA
Gene; 2018 Nov; 677():211-227. PubMed ID: 30059751
[TBL] [Abstract][Full Text] [Related]
11.
Yang P; Wang M; Tian T; Feng Y; Zheng Y; Yang T; Li H; Lin S; Xu P; Deng Y; Hao Q; Li N; Guan F; Dai Z
Cancer Manag Res; 2018; 10():1791-1798. PubMed ID: 30013390
[TBL] [Abstract][Full Text] [Related]
12. Association of functional MMP-2 gene variant with intracranial aneurysms: case-control genetic association study and meta-analysis.
Alg VS; Ke X; Grieve J; Bonner S; Walsh DC; Bulters D; Kitchen N; Houlden H; Werring DJ;
Br J Neurosurg; 2018 Jun; 32(3):255-259. PubMed ID: 29334797
[TBL] [Abstract][Full Text] [Related]
13. Association of SOX17 Gene Polymorphisms and Intracranial Aneurysm: A Case-Control Study and Meta-Analysis.
Hong EP; Kim BJ; Kim C; Choi HJ; Jeon JP
World Neurosurg; 2018 Feb; 110():e823-e829. PubMed ID: 29191544
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Identification of Potential Pleiotropic Genetic Variants for Bone Mineral Density and Breast Cancer.
Peng C; Lou HL; Liu F; Shen J; Lin X; Zeng CP; Long JR; Su KJ; Zhang L; Greenbaum J; Deng WF; Li YM; Deng HW
Calcif Tissue Int; 2017 Nov; 101(5):489-500. PubMed ID: 28761973
[TBL] [Abstract][Full Text] [Related]
15. The Role of DNA Repair (
Crișan AS; Tripon F; Bogliș A; Crauciuc GA; Trifa AP; Lázár E; Macarie I; Gabor MR; Bănescu C
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541232
[No Abstract] [Full Text] [Related]
16. DNA repair pathways in breast cancer: from mechanisms to clinical applications.
Tufail M
Breast Cancer Res Treat; 2023 Aug; 200(3):305-321. PubMed ID: 37289340
[TBL] [Abstract][Full Text] [Related]
17. Combined GSTT1 Null, GSTM1 Null and XPD Lys/Lys Genetic Polymorphisms and Their Association with Increased Risk of Chronic Myeloid Leukemia.
Abdalhabib EK; Jackson DE; Alzahrani B; Elfaki EM; Hamza A; Alanazi F; Ali EI; Algarni A; Ibrahim IK; Saboor M
Pharmgenomics Pers Med; 2021; 14():1661-1667. PubMed ID: 34992428
[TBL] [Abstract][Full Text] [Related]
18. CometChip enables parallel analysis of multiple DNA repair activities.
Ge J; Ngo LP; Kaushal S; Tay IJ; Thadhani E; Kay JE; Mazzucato P; Chow DN; Fessler JL; Weingeist DM; Sobol RW; Samson LD; Floyd SR; Engelward BP
DNA Repair (Amst); 2021 Oct; 106():103176. PubMed ID: 34365116
[TBL] [Abstract][Full Text] [Related]
19. Association between NER pathway gene polymorphisms and neuroblastoma risk in an eastern Chinese population.
Zhou C; Wang Y; He L; Zhu J; Li J; Tang Y; Zhou H; He J; Wu H
Mol Ther Oncolytics; 2021 Mar; 20():3-11. PubMed ID: 33575466
[TBL] [Abstract][Full Text] [Related]
20. Effects of Xeroderma pigmentosum group C polymorphism on the likelihood of prostate cancer.
Yan Y; Xu J; Xu B; Wen Q; Zhou J; Zhang L; Zuo L; Lv G; Shi Y
J Clin Lab Anal; 2020 Sep; 34(9):e23403. PubMed ID: 32488882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
